Bortezomib/Daratumumab/Dexamethasone/Lenalidomide Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, daratumumab, dexamethasone and lenalidomide that can be used for the treatment of plasma cell (multiple) myeloma.

**Synonyms:** - Bortezomib-Daratumumab-Dexamethasone-Lenalidomide - Bortezomib-Daratumumab-Dexamethasone-Lenalidomide Regimen - Bortezomib-Lenalidomide-Dexamethasone Plus Daratumumab - Bortezomib/Daratumumab/Dexamethasone/Lenalidomide - Bortezomib/Lenalidomide/Dexamethasone Plus Daratumumab - Bortezomib/Lenalidomide/Dexamethasone Plus Daratumumab Regimen - D-RVD Regimen - Dara-RVd - Dara-RVd - Daratumumab-RVD - Darzalex-RVD - RVD Plus Darzalex - RVD Regimen Plus Daratumumab - Velcade/Revlimid/Dexamethasone-Darzalex